Palliative Sedation
Palliative Sedation
Palliative Sedation
Stepwise approach
Decision-making
1. At an early stage (where possible), discuss the wishes of the
patient with regard to palliative sedation in the last stages of
life and provide information about its possibilities and
restrictions.
2. If palliative sedation is being considered, check whether all
indications and conditions are met:
• the presence of one or more refractory symptom(s)
• expertise and consensus of the team; if deemed
necessary, consultation of an external expert (e.g., a
palliative care team)
• sedation in line with the wishes of the patient and/or his
family; make a clear distinction between a request for
sedation and a request for euthanasia
• life expectancy < 1-2 weeks (only in the case of deep
and continuous sedation)
3. Document the process of decision-making in the medical file
and inform all caregivers involved.
1
Management
1. Make agreements regarding the desired duration of sedation
(continuous or temporary/intermittent) and about
evaluation of its effect; document this clearly in the medical
file and inform all caregivers involved.
2. Make clear arrangements regarding the availability and
attainableness of all professional caregivers and explain to
the family how they can be contacted.
3. Consult, if necessary, with a palliative care team regarding
execution of the procedure.
4. In principle, use subcutaneous or intravenous administration
of sedatives according to the following schedule:
• Step 1: 10 mg bolus midazolam s.c., followed by 1.5 -
2.5 mg/hr s.c./i.v.; if the effect is insufficient, increase
the dose by 50% every 4 hours (always in combination
with a 5 mg bolus); use a lower starting dose and longer
interval if risk factors are present. At each dosage level,
an extra bolus of 5 mg s.c. may be administered every 2
hours if the effect is insufficient. At doses >20 mg/hr go
to step 2.
• Step 2: Levomepromazine 25 mg bolus (if required,
another bolus of 50 mg after 2 hours), followed by 0.5 -
8 mg/hr in combination with midazolam; if midazolam
and levomepromazine have insufficient effect, cease
both drugs and go to step 3.
2
• Step 3: Propofol 20 - 50 mg bolus i.v., followed by
20mg/hr i.v.; if the effect is insufficient, increase every
15 minutes by 10 mg/hr (drug administration under
supervision of an anaesthesiologist).
5. In case of a short estimated life expectancy (<24-48 hours),
use intermittent administration of sedatives:
• midazolam 6 dd 5-10 mg; if necessary, increase the dose
by 50% every 4 hours; an extra bolus may be
administered between administrations, if required.
• diazepam 10 mg rectally every hour until adequate
sedation is attained
• lorazepam sublingually 1-4 mg every 4 hours
• clonazepam sublingually 1-2,5 mg every 6 hours
6. Discontinue all unnecessary medication; continue
administration of morphine only to treat pain and/or
dyspnoea and adjust the dose to the (presumed) degree of
pain and/or dyspnoea; continue haloperidol in the case of
refractory delirium.
7. Take additional measures if necessary (urinary catheter,
prevention of bed sores, oral care, enema etc.).
8. Discontinue artificial nutrition and fluids in case of
continuous and deep sedation; consider superficial or
intermittent sedation if discontinuation or not starting fluids
is unwanted.
3
9. Evaluate the effect every 1-2 hours until a stable situation
has been achieved and thereafter at least once every 24
hours; titrate the dose according to the level of (dis)comfort
of the patient (proportionality). Adjust the dose of sedatives
where required.
10. Document the course of sedation in the medical file.
11. Pay attention to the load capacity of the informal and
professional care providers involved.
Source:
Palliative sedation
Landelijke richtlijn, Versie: 2.0